Effective antimicrobial activity of Cbf-K16 and Cbf-A7A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro

Journal of Peptide Science

Volumn 19, Issue 3, 2013, Pages 173-180

  Hao, Qingru ^a   Wang, Hui ^a   Wang, Jing ^a   Dou, Jie ^a   Zhang, Min ^a   Zhou, Weidong ^a   Zhou, Changlin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Antimicrobial activity; Antimicrobial peptide; Cytoplasmic membrane permeability; DNA binding; NDM 1

Indexed keywords

AGAROSE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA GALACTOSIDASE; BETA LACTAMASE; COLISTIN; IMIPENEM; KANAMYCIN; LYSYLPHENYLALANYLPHENYLALALNYLARGINYLLYSYLLEUCYLALANYLLYSYLSERLYVALYLLYSYLLYSYLALANYLALANYLLSYLLYSYLPHENYLALANYLPHENYLALANYLLYSYLLYSYLPROLYLARGINYLISOLEUCYLGLYCYLVALYLSERYLISOLEUCYLPROLYLPHENYLALANINE; LYSYLPHENYLALANYLPHENYLALALNYLARGINYLLYSYLLEUCYLLYSYLLYSYLSERLYVALYLLYSYLLYSYLARGINYLALANYLLSYLGLUTAMYLPHENYLALANYLPHENYLALANYLLYSYLLYSYLPROLYLARGINYLISOLEUCYLGLYCYLVALYLSERYLISOLEUCYLPROLYLPHENYLALANINE; LYSYLPHENYLALANYLPHENYLALALNYLARGINYLLYSYLLEUCYLLYSYLLYSYLSERLYVALYLLYSYLLYSYLARGINYLALANYLLSYLLYSYLPHENYLALANYLPHENYLALANYLLYSYLLYSYLPROLYLARGINYLISOLEUCYLGLYCYLVALYLSERYLISOLEUCYLPROLYLPHENYLALANINE; MEROPENEM; NEW DELHI METALLO BETA LACTAMASE 1; PENICILLIN V; SYNTHETIC PEPTIDE; TIGECYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CELL MEMBRANE PERMEABILITY; COLONY FORMING UNIT; DRUG DNA BINDING; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE INSERTION; GENETIC TRANSFORMATION; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CATHELICIDINS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DNA, BACTERIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); BUNGARUS FASCIATUS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 84874020389     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2488     Document Type: Article

References (29)

1. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 2009; 53: 5046-5054.
2. El-Herte RI, Kanj SS, Matar GM, Araj GF. The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: an update on the regional and local epidemiology. J. Infect. Public Health 2012; 5: 233-243.
3. Peirano G, Schreckenberger PC, Pitout JDD. Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob. Agents Chemother. 2011; 55: 2986-2988.
4. Liang Z, Li L, Wang Y, Chen L, Kong X, Hong Y, Lan L, Zheng M, Guang-Yang C, Liu H, Shen X, Luo C, Li KK, Chen K, Jiang H. Molecular basis of NDM-1, a new antibiotic resistance determinant. PLoS One 2011; 6: e23606.
5. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 2010; 10: 597-602.
6. Guo Y, Wang J, Niu G, Shui W, Sun Y, Zhou H, Zhang Y, Yang C, Lou Z, Rao Z. A structural view of the antibiotic degradation enzyme NDM-1 from a superbug. Protein Cell 2011; 2: 384-394.
7. Solé M, Pitart C, Roca I, Fàbrega A, Salvador P, Muñoz L, Oliveira I, Gascón J, Marco F, Vila J. First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob. Agents Chemother. 2011; 55: 4402-4404.
8. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 2011; 11: 355-362.
9. Poirel L, Bonnin RA, Nordmann P. Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing. Antimicrob. Agents Chemother. 2011; 55: 4224-4229.
10. Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob. Agents Chemother. 2010; 54: 4914-4916.
11. Moellering Jr. RC. NDM-1-a cause for worldwide concern. New Engl. J. Med. 2010; 363: 2377-2379.
12. Di Nardo A, Yamasaki K, Dorschner RA, Lai Y, Gallo RL. Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin. J. Immunol. 2008; 180: 7565-7573.
13. Chongsiriwatana NP, Patch JA, Czyzewski AM, Dohm MT, Ivankin A, Gidalevitz D, Zuckermann RN, Barron AE. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. U.S.A. 2008; 105: 2794-2799.
14. Pag U, Oedenkoven M, Sass V, Shai Y, Shamova O, Antcheva N, Tossi A, Sahl H-G. Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an α-helical 'sequence template'. J. Antimicrob. Chemother. 2008; 61: 341-352.
15. Rossignol T, Kelly B, Dobson C, d'Enfert C. Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans. Antimicrob. Agents Chemother. 2011; 55: 4670-4681.
16. Zhou H, Dou J, Wang J, Chen L, Wang H, Zhou W, Li Y, Zhou C. The antimicrobial activity of BF-30 in vitro and in infected burned rats is through interference with cytoplasmic membrane integrity. Peptides 2011; 32: 1131-1138.
17. Wang Y, Hong J, Liu X, Yang H, Liu R, Wu J, Wang A, Lin D, Lai R. Snake cathelicidin from Bungarus fasciatusis a potent peptide antibiotics. PLoS One 2008; 3: e3217.
18. Diene SM, Bruder N, Raoult D, Rolain J-M. Real-time PCR assay allows detection of the New Delhi metallo-β-lactamase (NDM-1)-encoding gene in France. Int. J. Antimicrob. Agents 2011; 37: 544-546.
19. Choudhuri BS, Bhakta S, Barik R, Basu J, Kundu M, Chakrabarti P. Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. Biochem. J. 2002; 367: 279-285.
20. Huang W, Beharry Z, Zhang Z, Palzkill T. A broad-spectrum peptide inhibitor of β-lactamase identified using phage display and peptide arrays. Protein Eng. 2003; 16: 853-860.
21. Docobo-Pérez F, Nordmann P, Domínguez-Herrera J, López-Rojas R, Smani Y, Poirel L, Pachón J. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli. Int. J. Antimicrob. Agents 2012; 39: 251-254.
22. Poirel L, Revathi G, Bernabeu S, Nordmann P. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob. Agents Chemother. 2011; 55: 934-936.
23. Epand RF, Sarig H, Mor A, Epand RM. Cell-wall interactions and the selective bacteriostatic activity of a miniature Oligo-Acyl-Lysyl. Biophys. J. 2009; 97: 2250-2257.
24. Y Hui Bai HY You, Meng J, Xue X, Hou Z, Zhou Y, Ma X, Sang G, Luo X. Antisense inhibition of gene expression and growth in gram-negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene. Biomaterials 2012; 33: 659-667.
25. Belley A, Neesham-Grenon E, McKay G, Arhin FF, Harris R, Beveridge T, Parr TR Jr, Moeck G. Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro. Antimicrob. Agents Chemother. 2009; 53: 918-925.
26. Hao G, Shi Y, Tang Y, Le G. The membrane action mechanism of analogs of the antimicrobial peptide Buforin 2. Peptides 2009; 30: 1421-1427.
27. Mannoor MS, Zhang S, Link AJ, McAlpine MC. Electrical detection of pathogenic bacteria via immobilized antimicrobial peptides. Proc. Natl. Acad. Sci. U.S.A. 2010; 107: 19207-19212.
28. Wu G, Li X, Fan X, Wu H, Wang S, Shen Z, Xi T. The activity of antimicrobial peptide S-thanatin is independent on multidrug-resistant spectrum of bacteria. Peptides 2011; 32: 1139-1145.
29. Li Y, Xiang Q, Zhang Q, Huang Y, S Zhijian Overview on the recent study of antimicrobial peptides: origins, functions, relative mechanisms and application. Peptides 2012; 37: 207-215.